Status:
COMPLETED
Type 2 Diabetes Treatment and Remission With a Very Low-Calorie Ketogenic Diet (VLCKD) and Lifestyle Changes
Lead Sponsor:
Cabinet Medical
Collaborating Sponsors:
Trialance SCCL
Conditions:
Type 2 Diabetes Mellitus
Overweight and Obesity
Eligibility:
All Genders
18+ years
Brief Summary
There is a strong correlation between being overweight, specifically with abdominal fat, and type 2 diabetes mellitus (T2DM). Recent scientific literature has highlighted the connection between signif...
Detailed Description
The investigator wishes to carry out an observational, retrospective, uncontrolled, monocentric analysis on a group of patients with overweight and type 2 diabetes mellitus (T2DM). The analysis will ...
Eligibility Criteria
Inclusion
- Have a diagnosis of type 2 diabetes
- Being overweight (BMI \> 25 kg/m\^2) or obesity (BMI \> 29.9 kg/m\^2)
- Have wished to engage in a weight loss program according to the PnK® method
- Have accepted and signed the consent for the use of data
Exclusion
- Pregnancy or lactation
- Type 1 diabetes
- Eating disorders
- Psychiatric disorders
- Have any contraindication for doing the active or ketogenic phase
Key Trial Info
Start Date :
January 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 2 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT05984459
Start Date
January 30 2023
End Date
October 2 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Daniela Sofra
Lausanne, Switzerland, 1003